XML 36 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1

INTELLECTUAL PROPERTY LITIGATION EXPENSES (INCOME), NET	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
INTELLECTUAL PROPERTY LITIGATION EXPENSES (INCOME), NET	INTELLECTUAL PROPERTY LITIGATION EXPENSES (INCOME), NET The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $214.0 million, $39.2 million and $32.6 million during 2018, 2017 and 2016, respectively. In January 2019, the Company reached an agreement with Boston Scientific Corporation ("Boston Scientific") to settle all outstanding patent disputes for a one-time payment to Boston Scientific of $180.0 million, which was included in as an expense in 2018. The settlement covers alleged past damages and no further royalties will be owed by either party. In November 2017, the Company recorded a $112.5 million litigation gain related to the theft of trade secrets.

X

- References

No definition available.

+ Details

Name:	us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

+ Details

Name:	us-gaap_LegalMattersAndContingenciesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration